Technical Analysis for BLU - BELLUS Health Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Historical BLU trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 20 DMA Support | Bullish | 8.85% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 8.85% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics for conditions with high unmet medical need. Its lead drug candidate includes BLU-5937, a small molecule antagonist of the P2X3 receptor for chronic cough. The company also has economic interests in various partnered development stage programs, including KIACTA for the treatment of sarcoidosis; AMO-01 for treatment of Phelan McDermid syndrome; and ALZ-801 for APOE4 homozygous Alzheimer's disease. BELLUS Health Inc. was founded in 1993 and is headquartered in Laval, Canada.
Biopharmaceutical Life Sciences Biology Alzheimer's Disease Specialty Drugs Abdominal Pain Cough Chronic Cough
Biopharmaceutical Life Sciences Biology Alzheimer's Disease Specialty Drugs Abdominal Pain Cough Chronic Cough
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.13 |
| 52 Week Low | 2.97 |
| Average Volume | 210,451 |
| 200-Day Moving Average | 6.98 |
| 50-Day Moving Average | 8.17 |
| 20-Day Moving Average | 8.99 |
| 10-Day Moving Average | 9.27 |
| Average True Range | 0.50 |
| ADX | 25.79 |
| +DI | 31.36 |
| -DI | 15.26 |
| Chandelier Exit (Long, 3 ATRs ) | 8.62 |
| Chandelier Exit (Short, 3 ATRs ) | 9.51 |
| Upper Bollinger Band | 9.80 |
| Lower Bollinger Band | 8.18 |
| Percent B (%b) | 1.1 |
| BandWidth | 18.06 |
| MACD Line | 0.33 |
| MACD Signal Line | 0.32 |
| MACD Histogram | 0.0066 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.34 | ||||
| Resistance 3 (R3) | 11.24 | 10.69 | 11.11 | ||
| Resistance 2 (R2) | 10.69 | 10.34 | 10.74 | 11.03 | |
| Resistance 1 (R1) | 10.32 | 10.12 | 10.51 | 10.42 | 10.96 |
| Pivot Point | 9.77 | 9.77 | 9.86 | 9.82 | 9.77 |
| Support 1 (S1) | 9.40 | 9.42 | 9.59 | 9.50 | 8.96 |
| Support 2 (S2) | 8.85 | 9.20 | 8.90 | 8.89 | |
| Support 3 (S3) | 8.48 | 8.85 | 8.81 | ||
| Support 4 (S4) | 8.58 |
